A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/22 (2006.01) A61K 9/50 (2006.01) A61K 9/52 (2006.01) A61K 9/70 (2006.01) A61K 31/135 (2006.01) A61K 31/137 (2006.01) A61P 13/10 (2006.01)
Patent
CA 2311755
A method and formulation for treating unstable or overactive urinary bladder, wherein tolterodine or a tolterodine-related compound, or a pharmaceutically acceptable salt thereof, is administered to a patient in a pharmaceutically effective amount thereof through a controlled release formulation that administers tolterodine or said tolterodine-related compound, or salt thereof, at a controlled rate for at least 24 hours.
La thérapie et la formulation de l'invention s'adressent à des pathologies d'instabilité ou de réactivité excessive de la vessie. On utilise à cet effet la toltérodine, un composé à base de toltérodine, ou l'un de ses sels admis en pharmacie. On en administre au patient une quantité suffisante au moyen d'une formulation à libération contrôlée qui en assure une administration prolongée sur un cycle d'au moins 24 heures.
Gren Torkel
Hallen Bengt
Hoeck Ulla
Kreilgard Bo
Kristensen Helle
Gowling Lafleur Henderson Llp
Pfizer Health Ab
Pharmacia & Upjohn Ab
LandOfFree
Therapeutic formulation for administering tolterodine with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic formulation for administering tolterodine with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic formulation for administering tolterodine with... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1883742